Thesis plan
WAIST-HEIGHT RATIO IN PATIENTS WITH MODIFIABLE CARDIOVASCULAR RISK FACTORS.
Abstract:
Introduction:
Materials:
Study design: Observational prospective study.
Place of study: Out-patients and In-patients of department of general medicine in Kamineni institute of medical sciences.
Period of study: October 2017 to September 2019.
Inclusion criteria:
*Patients with type 2 diabetes mellitus:Any combination of
1.Fasting plasma glucose more than or equal to 7mmol/L(126mg/dl)
2. 2-hour Plasma glucose more than or equal to
11mmol/L(200mg/dl) or
3.Patients with physician diagnosis of diabetes or
4.Patients receiving anti-diabetic medication.
*Patients with Dyslipidemia-
1. Patients on Treatment for dyslipidemia or
2.Two or more abnormal serum lipid measurements including
-Total cholesterol more than equal to 270mg/dl
-LDL cholesterol more than or equal to 188mg/dl
-Triglycerides more than or equal to 150mg/dl
-HDL cholesterol less than or equal to 44mg/dl
*Patients with Obesity. (BMI more than or equal to 30)
Abstract:
Introduction:
Definition
of Hypertension according to National Institute of Health and Care Excellence
guideline
is Clinical Blood Pressure of 140/90mmHg or higher and subsequent ambulatory blood pressure
monitoring daytime average or home blood pressure monitoring average is 135/85 mmHg or higher.
is Clinical Blood Pressure of 140/90mmHg or higher and subsequent ambulatory blood pressure
monitoring daytime average or home blood pressure monitoring average is 135/85 mmHg or higher.
Materials:
Study design: Observational prospective study.
Place of study: Out-patients and In-patients of department of general medicine in Kamineni institute of medical sciences.
Period of study: October 2017 to September 2019.
Inclusion criteria:
*Patients
more than 18 years of age will be included, both the males and females.
Patients
with elevated blood pressure-Any combination of
1.Systolic blood pressure more than or
equal to 140mmhg and/or,
2.Diastolic blood pressure more than or equal to 90mmhg and/or,
3.Patients with physician diagnosis of hypertension and/or,
4.Patients receiving anti-hypertensive medication.
2.Diastolic blood pressure more than or equal to 90mmhg and/or,
3.Patients with physician diagnosis of hypertension and/or,
4.Patients receiving anti-hypertensive medication.
*Patients with type 2 diabetes mellitus:Any combination of
1.Fasting plasma glucose more than or equal to 7mmol/L(126mg/dl)
2. 2-hour Plasma glucose more than or equal to
11mmol/L(200mg/dl) or
3.Patients with physician diagnosis of diabetes or
4.Patients receiving anti-diabetic medication.
*Patients with Dyslipidemia-
1. Patients on Treatment for dyslipidemia or
2.Two or more abnormal serum lipid measurements including
-Total cholesterol more than equal to 270mg/dl
-LDL cholesterol more than or equal to 188mg/dl
-Triglycerides more than or equal to 150mg/dl
-HDL cholesterol less than or equal to 44mg/dl
*Patients with Obesity. (BMI more than or equal to 30)
Exclusion criteria:
Patients
who can produce falsely elevated anthropometric parameter, Waist circumference
and weight due to-
1.Patients with Ascites and Volume
overload.
2.Patients with Hypothyroidism.
3.Short stature.
Methodology:
Questionnaire interview
Anthropometric measurements
Blood Pressure recordings
Investigations
References:
Comments
Post a Comment